Machine learning in the market scale of the pharmaceutical industry.jpg
DUBLIN, June 6, 2023 (Globe Newswire) — The Global Machine Learning in Pharmaceutical Industry Market Size, Share and Industry Trends Analysis Report by Component (Solutions and Services), Deployment Mode (Cloud and On-Premises) ), Size by Organization, Outlook and Forecast by Region, 2023-2029 report added of ResearchAndMarkets.com Recruitment.
The global machine learning market size in the pharmaceutical industry is expected to reach $11.4 billion by 2029, growing at a CAGR of 34.4% during the forecast period.
major market players
-
Google LLC (Alphabet)
-
NVIDIA Corporation
-
IBM Corporation
-
microsoft
-
Cyclica Co., Ltd.
-
Biosymmetry, Inc.
-
Crowd Pharmaceuticals, Inc.
-
Deep Genomics Inc.
-
Atomwise Co., Ltd.
The purpose of machine learning in the pharmaceutical industry is to advance medical knowledge, not replace doctors. A physician’s entire knowledge, including everything they learned during medical school and residency, in addition to their experience treating patients, will be augmented to unprecedented levels by artificial intelligence algorithms.
Ability to acquire and process the vast amount of data available to physicians, such as new treatments, disease symptoms, drug interactions, and how different patients treated with the same method have different outcomes are rapidly emerging as key talent. And machine learning allows us to make inferences from that data and put them into action.
For example, by collecting data from many patient visits and thousands of doctors, machine learning systems can quickly identify rare diseases, refer to available treatments, and prescribe them. increase. The result is time savings, increased efficiency and reduced costs.
Machine learning can also prevent recidivism by helping track cases and providing additional recommendations. AI is integrated with electronic medical records. When doctors use them irregularly, they get pop-ups explaining how certain genetic traits affect a patient’s condition, or how new medicines might improve their health. Doctors can click pop-ups to better understand the disease and recommend the best course of treatment.
Not only do these electronic records save time and space, they actively help doctors suggest better treatments and educate them about the details at hand. Some countries with high numbers of lung cancer patients have started implementing AI programs that allow doctors to better diagnose lung cancer patients by analyzing her X-rays and CT scans and spotting suspicious nodules and lesions. I’m here.
Market growth factors
anticipate the epidemic
Companies are leveraging AI and machine learning to give users the exact location and dates of upcoming outbreaks, such as dengue epidemics, months in advance. The program also proposes dengue countermeasures within a few hundred meters of contaminated areas.
Machine learning can therefore help researchers predict when and where an impending epidemic will occur, alert relevant authorities, and inform the public about it. This feature has the potential to save many lives and is expected to increase the adoption of machine learning and open up new growth opportunities in the market.
Increased use of technology in the healthcare industry
Using electronic summaries instead of paper makes patient care simpler and more productive. Advances in future genomes (and vast genomes of commensal bacteria) and personalized therapies will greatly increase the amount of information available.
As more patient data is collected, more insights become available. Increasing utilization of machine learning in the pharmaceutical industry is expected to drive market growth due to various benefits such as cost reduction, management, and collection of large amounts of patient data for future reference.
market impediments
data inconsistency
When many data sources are used, it is difficult to reconcile all the data and perform analysis on the data set. Companies that choose point solutions or do not have robust data analysis systems must manually compile analytical reports and insights. Such procedures are time consuming and may not provide real business relevant insights. Therefore, data-related issues are expected to hinder machine learning in expanding the pharmaceutical industry market.
scope of research
By component
By deployment mode
By organization size
For more information on this report, please visit https://www.researchandmarkets.com/r/7daeu5.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
